A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial
Titel:
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial
Auteur:
Kulke, M.H. Ruszniewski, P. Van Cutsem, E. Lombard-Bohas, C. Valle, J.W. De Herder, W.W. Pavel, M. Degtyarev, E. Brase, J.C. Bubuteishvili-Pacaud, L. Voi, M. Salazar, R. Borbath, I. Fazio, N. Smith, D. Capdevila, J. Riechelmann, R.P. Yao, J.C.